In the patients with gastrointestinal stromal tumours (GISTs), RKIP expression levels correlate with clinical-pathological factors, and loss of RKIP expression is associated with poor survival [20]. This evidence concerns the gene PEBP1 and gastrointestinal stromal tumor.